F-18 fluorodeoxyglucose positron emission tomography in the non-invasive staging of non-small cell lung cancer

European Journal of Cardio-thoracic Surgery

Volumn 16, Issue SUPPL. 1, 1999, Pages

  Berlangieri, Salvatore U ^a   Scott, Andrew M ^a,b   Knight, Simon R ^a   Fitt, Gregory J ^a   Hennessy, Oliver F ^c   Tochon Danguy, Henri J ^a   Peter Clarke, C ^a   John McKay, W ^a  

^a AUSTIN HEALTH   (Australia)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

Author keywords

Fluorodeoxyglucose; Lung cancer staging; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; MALE; MEDIASTINOSCOPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; THORACOTOMY;

ADULT; AGED; CARCINOMA IN SITU; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0032828473     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(99)00179-7     Document Type: Conference Paper

References (25)

1. Minna JD. Neoplasms of the lung. In: Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL, editors. Harrison's principles of internal medicine. New York: McGraw-Hill, 1998:552-562.
2. McLoud T.C., Bourgouin P.M., Greenberg R.W., Kosiuk J.P., Templeton P.A., Shepard J.O., Moore E.H., Wain J.C., Mathisen D.J., Grillo H.C. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology. 182:1992;319-332.
3. Di Chiro G., DeLaPaz R.L., Brooks R.A., Sokoloff L., Kornblith P.L., Smith B.H., Patronas N.J., Kufta C.V., Kessler R.M. Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography. Neurology. 32:1982;1323-1329.
4. Di Chiro G., Oldfield E., Wright D.C., De M.D., Katz D.A., Patronas N.J., Doppman J.L., Larson S.M., Ito M. Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: positron emission tomography and neuropathologic studies. Am J Roentgenol. 150:1988;189-197.
5. Gupta N.C., Frank A.R., Dewan N.A., Redepenning L.S., Rothberg M.L., Mailliard J.A., Phalen J.J., Sunderland J.J., Frick M.P. Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology. 184:1992;441-444.
6. Dewan N.A., Gupta N.C., Redepenning L.S., Phalen J.J., Frick M.P. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management. Chest. 104:1993;997-1002.
7. Strauss L.G., Conti P.S. The applications of PET in clinical oncology. J Nucl Med. 32:1991;623-648.
8. Patz E.J., Lowe V.J., Hoffman J.M., Paine S.S., Burrowes P., Coleman R.E., Goodman P.C. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology. 188:1993;487-490.
9. Wienhard K., Dahlbom M., Eriksson L., Michel C., Bruckbauer T., Pietrzyk U., Heiss W.D. The ECAT EXACT HR: performance of a new high resolution positron scanner. J Comput Assist Tomogr. 18:1994;110-118.
10. De Grado T.R., Turkington T.G., Williams J.J., Stearns C.W., Hoffman J.M., Coleman R.E. Performance characteristics of a whole-body PET scanner. J Nucl Med. 35:1994;1398-1406.
11. Wahl R.L., Quint L.E., Greenough R.L., Meyer C.R., White R.I., Orringer M.B. Staging of mediastinal non-small cell lung cancer with FDG PET CT, and fusion images: preliminary prospective evaluation. Radiology. 191:1994;371-377.
12. Valk P.E., Pounds T.R., Hopkins D.M., Haseman M.K., Hofer G.A., Greiss H.B., Myers R.W., Lutrin C.L. Staging non-small cell lung cancer by whole-body positron emission tomographic imaging. Ann Thorac Surg. 60:1995;1572-1581.
13. Vansteenkiste J.F., Stroobants S.G., De Leyn P.R., Dupont P.J., Bogaert J., Maes A., Deneffe G.J., Nackaerts K.L., Verschakelen J.A., Lerut T.E., Mortelmans L.A., Demedts M.G. Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients. J Clin Oncol. 16:1998;2142-2149.
14. Chin R. Jr, Ward R., Keyes J.W., Choplin R.H., Reed J.C., Wallenhaupt S., Hudspeth A.S., Haponik E.F. Mediastinal staging of non-small-cell lung cancer with positron emission tomography. Am J Respir Crit Care Med. 152:1995;2090-2096.
15. Bury T., Paulus P., Dowlati A., Corhay J.L., Weber T., Ghaye B., Schoffers J., Limet R., Albert A., Rigo P., Radermecker M. Staging of the mediastinum: value of positron emission tomography imaging in non-small cell lung cancer. Eur Respir J. 9:1996;2560-2564.
16. Steinert H.C., Hauser M., Allemann F., Engel H., Berthold T., von Schulthess G.K., Weder W. Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. Radiology. 202:1997;441-446.
17. Dahlbom M., Hoffman E.J., Hoh C.K., Schiepers C., Rosenqvist G., Hawkins R.A., Phelps M.E. Whole-body positron emission tomography: Part I Methods and performance characteristics. J Nucl Med. 33:1992;1191-1199.
18. Sazon D.A., Santiago S.M., Soo Hoo G.W., Khonsary A., Brown C., Mandelkern M., Blahd W., Williams A.J. Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer. Am J Respir Crit Care Med. 153:1996;417-421.
19. Lewis P., Griffin S., Marsden P., Gee T., Nunan T., Malsey M., Dussek J. Whole-body 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer. Lancet. 344:1994;1265-1266.
20. Meikle S.R., Dahlbom M., Cherry S.R. Attenuation correction using count-limited transmission data in positron emission tomography. J Nucl Med. 34:1993;143-150.
21. Hamacher K., Coenen H.H., Stocklin G. Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2- deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med. 27:1986;235-238.
22. Genereux G.P., Howie J.L. Normal mediastinal lymph node size and number: CT and anatomic study. Am J Roentgenol. 142:1984;1095-1100.
23. Dwyer A.J. Matchmaking and McNemar in the comparison of diagnostic modalities. Radiology. 178:1991;328-330.
24. Lewis P.J., Salama A. Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis. J Nucl Med. 35:1994;1647-1649.
25. Yu J.N., Fahey F.H., Gage H.D., Eades C.G., Harkness B.A., Pelizzari C.A., Keyes J.J. Intermodality, retrospective image registration in the thorax. J Nucl Med. 36:1995;2333-2338.